Comparing two types of scans for lung cancer detection
Part of Cancer, Lungs & breathing clinical trials.
This trial compares a new type of imaging scan (SPECT/CT) to the standard PET/CT scan to see if it can help diagnose and monitor lung cancer just as well. If you have lung cancer and are about to start treatment, you may be able to join to help test this new method.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have been diagnosed with lung cancer (either by biopsy or CT scan) or agree to have a biopsy within 15 days of the scan.
- You cannot be currently receiving cancer treatment (surgery, radiation, or chemotherapy).
- Your blood glucose must be under 200 mg/dL (you'll be tested), and you must be able to fast for 6 hours before the scan.
- You must be able to lie still with your arms overhead for about 45 minutes, without feeling claustrophobic.
- If you are of childbearing age, you must agree to use birth control and have a negative pregnancy test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer PET/CT scan method to detect uncertain (indeterminate) lung nodules more accurately before biopsy or surgery. If you have a small lung nodule that doctors are still unsure about, this could help improve how nodules are found and assessed.
This study uses a computer-generated PET scan from your CT scan to help doctors diagnose and plan treatment for non-small cell lung cancer more precisely. It is observational, meaning no new treatments are given—just extra imaging analysis.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
This study tests a new imaging dye (called a probe) that targets a specific change in lung cancer cells (EGFR mutation). The PET/CT scan uses this dye to see if the tumor can be clearly seen, which might help doctors plan better treatment.
This trial is testing a new radioactive imaging agent that targets a protein called Nectin-4, which is often found on lung tumors. The scan will help doctors see if the tumor is visible and how it spreads, which may guide better treatment decisions for lung cancer patients.
This study tests whether a special imaging scan using a radioactive sugar (18F-FDG) can help doctors better examine lung cancer tissue during thoracic surgery. You may be offered the scan around the time of your operation to help researchers learn how well it works.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.